Physiol. Genomics Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (December 28, 2004). doi:10.1152/physiolgenomics.00165.2004 Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/3/256    most recent
00165.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wellner, M.
Right arrow Articles by Muller, D. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wellner, M.
Right arrow Articles by Muller, D. N
Submitted on July 28, 2004
Accepted on December 17, 2004

Cardiac Gene Expression Profile in Rats with Terminal Heart Failure and Cachexia

Maren Wellner1, Ralf Dechend1, Joon-Keun Park2, Erdenechimeg Shagdasuren1, Nidal Al-Saadi1, Torsten Kirsch2, Petra Gratze1, Wolfgang Schneider1, Silke Meiners3, Anette Fiebeler1, Hermann Haller2, Friedrich C Luft4, and Dominik N Muller4*

1 Nephrology, HELIOS Klinikum-Berlin, Franz Volhard Clinic and Medical Faculty of the Charite Humboldt University of Berlin, Berlin, Germany
2 Nephrology, Department of Medicine, Hannover Medical School, Hannover, Germany
3 Cardiology, Department of Cardiology, Charite Campus Mitte, Berlin, Berlin, Germany
4 Nephrology, HELIOS Klinikum-Berlin, Franz Volhard Clinic and Medical Faculty of the Charite Humboldt University of Berlin, Berlin, Germany; Cardiology, Max-Delbruck-Center for CMolecular Medicine, Berlin and Franz Volhard Clinic and Medical Faculty of theharite, Humboldt University of Berlin, Berlin, Germany

* To whom correspondence should be addressed. E-mail: mueller{at}fvk-berlin.de.

About half of double transgenic rats (dTGR) over-expressing the human renin and angiotensinogen genes die by age 7 weeks of terminal heart failure (THF); the other (preterminal) half develops cardiac damage, but survives to week 7. The aim of our study was to elucidate the difference in cardiac gene expression of dTGR with THF compared to dTGR showing compensated cardiac hypertrophy, but not yet THF. Non-transgenic rats (SD) served as control. We also examined the effect of the AT1 receptor blocker losartan (LOS) on gene expression and cardiac injury. THF-dTGR body weight was significantly lower than all other groups. At sacrifice, THF-dTGR had blood pressures of 228±7 mm Hg; cardiac hypertrophy index 6.2±0.1 mg/g. Tissue Doppler measurements showed a reduced peak early (Ea) and late (Aa) diastolic expansion velocities in THF-dTGR indicating diastolic function (Ea<Aa). Preterminal dTGR had blood pressures of 197±5 mm Hg; cardiac hypertrophy index 5.1±0.1 mg/g; Ea<Aa. LOS-dTGR had blood pressures of 141±6 mm Hg; cardiac hypertrophy index 3.7±0.1 mg/g; Ea>Aa. For SD, blood pressure was 112±4 mm Hg; cardiac hypertrophy index 3.6±0.1 mg/g; Ea>Aa. Left ventricular total RNA was isolated for the Affymetrix system and TaqMan RT-PCR. THF-dTGR and dTGR showed an up-regulation of several hypertrophy markers and a {alpha}/{beta}-MHC switch to the fetal isoform. THF-dTGR (vs. dTGR) showed an up-regulation of 239 and down-regulation of 150 genes. Various genes of the mitochodrial respiratory chain and lipid catabolism were reduced. In addition, genes encoding the transcription factors (CEBP-beta, c-fos, Fra-1), coagulation (PAI-1, t-PA, uPAR-1), remodeling/repair components (HSP70, HSP27, heme oxygenase, TIMP-1), immune system (complement components, MHC class I, IL-6, HSP70) and metabolic pathway genes (GLUT1, GLUT4, Phosphofructokinase) were differentially expressed. In contrast, LOS-dTGR and SD had similar expression profiles. These data show that THF-dTGR show an altered expression profile compared to preterminal dTGR. LOS reverts the expression profiles towards normal.




This article has been cited by other articles:


Home page
Reproductive SciencesHome page
F. Herse, Bai Youpeng, A. C. Staff, J. Yong-Meid, R. Dechend, and Zhou Rong
Circulating and Uteroplacental Adipocytokine Concentrations in Preeclampsia
Reproductive Sciences, June 1, 2009; 16(6): 584 - 590.
[Abstract] [PDF]


Home page
Eur J Heart FailHome page
C.-Y. Chen, B.-C. Lee, H.-C. Hsu, H.-J. Lin, C.-L. Chao, Y.-H. Lin, Y.-L. Ho, and M.-F. Chen
A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit
Eur J Heart Fail, August 1, 2008; 10(8): 740 - 748.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Fischer, R. Dechend, F. Qadri, M. Markovic, S. Feldt, F. Herse, J.-K. Park, A. Gapelyuk, I. Schwarz, U. B. Zacharzowsky, et al.
Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension
Hypertension, February 1, 2008; 51(2): 540 - 546.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Fischer, R. Dechend, A. Gapelyuk, E. Shagdarsuren, K. Gruner, A. Gruner, P. Gratze, F. Qadri, M. Wellner, A. Fiebeler, et al.
Angiotensin II-induced sudden arrhythmic death and electrical remodeling
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1242 - H1253.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-K. Park, R. Fischer, R. Dechend, E. Shagdarsuren, A. Gapeljuk, M. Wellner, S. Meiners, P. Gratze, N. Al-Saadi, S. Feldt, et al.
p38 Mitogen-Activated Protein Kinase Inhibition Ameliorates Angiotensin II-Induced Target Organ Damage
Hypertension, March 1, 2007; 49(3): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Herse, R. Dechend, N. K. Harsem, G. Wallukat, J. Janke, F. Qadri, L. Hering, D. N. Muller, F. C. Luft, and A. C. Staff
Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia
Hypertension, March 1, 2007; 49(3): 604 - 611.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Rajan, S. S. Williams, G. Jagatheesan, R. P. H. Ahmed, G. Fuller-Bicer, A. Schwartz, B. J. Aronow, and D. F. Wieczorek
Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy
Physiol Genomics, November 21, 2006; 27(3): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Cerutti, M. Kurdi, G. Bricca, W. Hodroj, C. Paultre, J. Randon, and M.-P. Gustin
Transcriptional alterations in the left ventricle of three hypertensive rat models
Physiol Genomics, November 21, 2006; 27(3): 295 - 308.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. Liang and B. Ventura
Physiological genomics in PG and beyond: July to September 2005
Physiol Genomics, October 17, 2005; 23(2): 119 - 124.
[Full Text] [PDF]


Home page
Circ. Res.Home page
E. Shagdarsuren, M. Wellner, J.-H. Braesen, J.-K. Park, A. Fiebeler, N. Henke, R. Dechend, P. Gratze, F. C. Luft, and D. N. Muller
Complement Activation in Angiotensin II-Induced Organ Damage
Circ. Res., September 30, 2005; 97(7): 716 - 724.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Pilz, E. Shagdarsuren, M. Wellner, A. Fiebeler, R. Dechend, P. Gratze, S. Meiners, D. L. Feldman, R. L. Webb, I. M. Garrelds, et al.
Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats
Hypertension, September 1, 2005; 46(3): 569 - 576.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.